Nav: Home

Indiana Biosciences Research Institute scientist receives $750,000 JDRF grant

September 07, 2016

INDIANAPOLIS, Ind., Sept. 7, 2016 - A researcher with the Indiana Biosciences Research Institute (IBRI) today received a 2016 Career Development Award from JDRF, the leading global organization funding type 1 diabetes (T1D) research. Teresa Mastracci, PhD, is a Senior Scientist at the IBRI.

"This award is confirmation of the impressive research Teresa is doing in the area of beta cell biology and type 1 diabetes," said Dr. Raghu Mirmira, Interim Chief Scientific Officer and Core Laboratories Director for the IBRI. "We look forward to seeing her translate her research in ways that will ultimately help children and adults afflicted with type 1 diabetes."

Mastracci will use the $750,000 award to continue her work in the area of beta cell regeneration. Her study will look at how polyamine and hypusine biosynthesis can be harnessed to reverse the progression of type 1 diabetes. Mastracci's goal is to identify new drugs that preserve or regenerate healthy beta cells, which will help to slow or even halt the progression of type 1 diabetes. Beta cells are the only cell type in the body that produces insulin, a hormone that is lacking in type 1 diabetes.

According to the Centers for Disease Control and Prevention, type 1 diabetes currently affects nearly 1 in 11 Americans. The World Health Organization estimates that worldwide 422 million adults have diabetes. Type 1 diabetes is sometimes referred to as "juvenile onset" because it is diagnosed in early childhood and requires lifelong insulin therapy.

The JDRF Career Development Award is designed to assist exceptionally promising researchers early in their careers. Past recipients of the award include Maike Sander, Director of the Pediatric Diabetes Research Center at the University of California San Diego; Mehboob Ali Hussain, Director of the Diabetes Center at Johns Hopkins University; and Matthias Hebrok, Director of the Diabetes Center at the University of California San Francisco. JDRF previously funded Mastracci's research in 2010 with a prestigious JDRF Postdoctoral Fellowship.

"I am grateful to JDRF for this honor and for their continued confidence in my research," said Mastracci. "This award provides my lab with the support we need to continue our discovery work to identify new tests and potential treatments that will directly impact people with type 1 diabetes."

In addition to working for the IBRI, Mastracci is an Adjunct Assistant Professor of Biochemistry & Molecular Biology at Indiana University School of Medicine.
-end-
About Indiana Biosciences Research Institute

The Indiana Biosciences Research Institute (IBRI) is an independent, nonprofit discovery and applied research institute focused on innovation targeting cardio-metabolic diseases, diabetes and poor nutrition. Inspired by the state and Indiana's leading life sciences companies, research universities and philanthropic community, the IBRI is building a world-class organization of researchers, innovators, and entrepreneurs that will catalyze scientific discovery and its application, resulting in improved health outcomes for patients. Initial funding has been provided by the State of Indiana, Lilly Endowment, Eli Lilly and Company, Dow AgroSciences, Roche Diagnostics, Indiana University Health and the Indiana University School of Medicine. For more information about IBRI and donation or collaboration opportunities, please visit http://www.indianabiosciences.org.

Contact:

Christy Denault
317/417-6322
cdenault@indianabiosciences.org

Indiana Biosciences Research Institute

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
More Diabetes News and Diabetes Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab